Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

• V. La,
• R. Fujikawa,
• D. M. Janzen,
• M. Nunez,
• L. Bainvoll,
• L. Hwang,
• K. Faull,
• G. Lawson,
• S. Memarzadeh

Affiliations

V. La

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles

R. Fujikawa

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles

D. M. Janzen

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles

M. Nunez

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles

L. Bainvoll

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles

L. Hwang

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles

K. Faull

Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles

G. Lawson

Office of Laboratory Animal Care, University of California Berkeley

S. Memarzadeh

Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles